BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26376597)

  • 1. Auer Rods in Chronic Myelomonocytic Leukemia Can Change the Diagnosis.
    Gajendra S; Sahoo RK
    Turk J Haematol; 2015 Sep; 32(3):278-9. PubMed ID: 26376597
    [No Abstract]   [Full Text] [Related]  

  • 2. Unusual skin lesions in chronic myelomonocytic leukemia.
    McCollum A; Bigelow CL; Elkins SL; Hardy CL; Files JC
    South Med J; 2003 Jul; 96(7):681-4. PubMed ID: 12940320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of Auer rods in childhood acute myelogenous leukemia: results of the studies AML-BFM-78 and -83.
    Ritter J; Vormoor J; Creutzig U; Schellong G
    Med Pediatr Oncol; 1989; 17(3):202-9. PubMed ID: 2546027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic myelomonocytic leukemia].
    Kalnberza GK; Rotsena AIa; Bondare DK; Teĭlane IIa; Grant KhIa
    Ter Arkh; 1988; 60(11):120-3. PubMed ID: 3238562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIT D816V- chronic myelomonocytic leukemia progressing to KIT D816V+ associated to mast cell leukemia responding to allogeneic hematopoietic cell transplantation.
    Prats-Martín C; Jiménez-Guerrero P; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; Pérez O; Montero I; Falantes J; Burillo-Sanz S; Carrillo E; Borrero JJ; Bernal R; Pérez-Simón JA
    Ann Hematol; 2018 Mar; 97(3):533-535. PubMed ID: 29151134
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple myeloma with Auer-rod-like inclusions.
    Castoldi G; Piva N; Tomasi P
    Haematologica; 1999 Sep; 84(9):859-60. PubMed ID: 10477463
    [No Abstract]   [Full Text] [Related]  

  • 7. Pseudo-Chédiak-Higashi inclusions in relapsed acute lymphoblastic leukaemia.
    Zhong ZQ; Zhuang HF; Wu SL; Zhang H
    Br J Haematol; 2021 Nov; 195(3):300. PubMed ID: 34166523
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myelodysplastic diseases in childhood].
    Niemeyer C; Stollmann-Gibbels B; Ebell W; Gaedicke G; Creutzig U
    Klin Padiatr; 1992; 204(4):190-7. PubMed ID: 1518255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic myelomonocytic leukemia in adults].
    Baudard M; Delmer A; Zittoun R
    Pathol Biol (Paris); 1997 Sep; 45(7):605-11. PubMed ID: 9404487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic myelomonocytic leukemia: from diagnosis to treatment].
    Hafraoui K; De Prijck B; Beguin Y
    Rev Med Suisse; 2013 Aug; 9(395):1512, 1514-7. PubMed ID: 24024420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcoidosis preceding chronic myelomonocytic leukemia. Report of two cases.
    Serratrice J; Granel B; Swiader L; Disdier P; Weiller-Merli C; Lepidi H; de Roux-Serratrice C; Andrac-Meyer L; Weiller PJ
    Dermatology; 2002; 205(4):409-12. PubMed ID: 12444342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cell surface antigen phenotype in guiding therapeutic decisions in chronic myelomonocytic leukemia.
    Woodlock TJ; Seshi B; Sham RL; Cyran EM; Bennett JM
    Leuk Res; 1994 Mar; 18(3):173-81. PubMed ID: 7511190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T618I-Mutated Colony Stimulating Factor 3 Receptor in Chronic Neutrophilic Leukemia and Chronic Myelomonocytic Leukemia Patients who Underwent Allogeneic Stem Cell Transplantation.
    Lee SE; Jo I; Jang W; Kim Y; Han K; Kim M
    Ann Lab Med; 2015 May; 35(3):376-8. PubMed ID: 25932451
    [No Abstract]   [Full Text] [Related]  

  • 14. Juvenile myelomonocytic leukemia in a child with Crohn disease.
    Oliver JW; Farnsworth B; Tonk VS
    Cancer Genet Cytogenet; 2006 May; 167(1):70-3. PubMed ID: 16682290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemic relapse in the central nervous system after allogeneic stem cell transplantation with complete remission in the bone marrow and donor-type chimerism: report of two cases.
    Ohashi H; Kato C; Fukami S; Saito H; Hamaguchi M
    Am J Hematol; 2005 Jun; 79(2):142-6. PubMed ID: 15929112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management.
    Parikh SA; Tefferi A
    Am J Hematol; 2012 Jun; 87(6):610-9. PubMed ID: 22615103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood leukemia.
    Hutter JJ
    Pediatr Rev; 2010 Jun; 31(6):234-41. PubMed ID: 20516235
    [No Abstract]   [Full Text] [Related]  

  • 18. [Incidence and prognostic significance of Auer rods in children with acute myeloid leukemia in the studies AML-BFM-78 and -83].
    Vormoor J; Ritter J; Creutzig U; Schellong G
    Klin Padiatr; 1989; 201(4):227-32. PubMed ID: 2674529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auer rods in a patient with chronic myelomonocytic leukemia type 2.
    Xu Z; Shier L
    Blood; 2014 Dec; 124(25):3828. PubMed ID: 25635282
    [No Abstract]   [Full Text] [Related]  

  • 20. Inclusion of secondary chronic myelomonocytic leukemia and myeloproliferative disease, unclassifiable, in classification of pediatric myeloproliferative disorders.
    Occhipinti E; Correa H; Yu L; Craver R
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):700-1. PubMed ID: 17023836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.